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Pachyonychia congenita (PC) is a rare genodermatosis affecting the nails, skin, oral mucosae, larynx, hair, and
teeth. Pathogenic mutations in keratins K6a or K16 are associated with the PC-1 phenotype whereas K6b and K17
mutations are associated with the PC-2 phenotype. Analysis of clinical, pathological, and genetic data from the
literature and two research registries reveal that >97% of PC cases exhibit ﬁngernail and toenail thickening, and
painful plantar keratoderma. Prospective evaluation of 57 PC patients from 41 families revealed variable clinical
ﬁndings: hyperhidrosis (79%), oral leukokeratosis (75%), follicular keratosis (65%), palmar keratoderma (60%),
cutaneous cysts (35%), hoarseness or laryngeal involvement (16%), coarse or twisted hair (26%), early primary
tooth loss (14%), and presence of natal or prenatal teeth (2%). Stratiﬁcation of these data by keratin mutation
conﬁrmed the increased incidence of cyst formation and natal teeth among PC-2 patients, although cysts were
more commonly seen in PC-1 than previously reported (25%–33%). Previously unreported clinical features of PC
include development of painful oral and nipple lesions during breastfeeding, copious production of waxy material
in ears, and inability to walk without an ambulatory aid (50%). Possible pathogenic mechanisms are discussed with
respect to the clinicopathologic and genetic correlations observed.
Key words: keratin/keratoderma/leukokeratosis/nails/pachyonychia
J Investig Dermatol Symp Proc 10:3 –17, 2005
Pachyonychia congenita (PC) is a rare, autosomal dominant
keratin disorder that typically affects the nails and palmo-
plantar skin, and often the oral mucosa, tongue, larynx,
teeth, and hair. Because of its rarity, the condition has been
difficult to characterize or investigate, and no controlled
prospective clinical trials have been published using this
patient population. Our understanding of the clinical and
pathological features of the disorder has been based upon
case reports, a few case series, and some excellent reviews
that have attempted to unify the case report literature
(Kumer, 1935; Moldenhauer and Ernst, 1968; Schonfeld,
1980; Franzot et al, 1981; Stieglitz and Centerwall, 1983;
Sivasundram et al, 1985; Feinstein et al, 1988; Su et al,
1990; Paller et al, 1991; Dahl et al, 1995). A comprehensive
bibliography of PC, complete with translations of non-Eng-
lish articles, is available at http://www.pachyonychia.org.
Unfortunately, many publications include photographs of
dramatic or unusual manifestations of the condition and
there is little discussion about the spectrum of clinical or
pathological phenotypes that may be observed. This bias
makes it extremely difficult for the average practitioner, who
may only see one or two cases in an entire career, to be
assured that they have made the correct diagnosis, espe-
cially in an individual without classic symptomatology.
History and classification of PC. The term pachyonychia
congenita (Greek: thick nails from birth) was coined by
Jadassohn and Lewandowski in 1906 and this case report
is frequently quoted as the original description of the con-
dition (Jadassohn and Lewandowski, 1906). But based on
the descriptions and photographs of cases reported by
Mu¨ller in 1904 and Wilson in 1905, it is likely that they were
also describing PC (Mu¨ller, 1904; Wilson, 1905). Jan Bonde-
son has performed a comprehensive review of the medical
history of PC (Bondeson, 1993). This paper provides com-
pelling evidence that St George Ash described an Irish case
of PC as early as 1685, and that the first reported case of
PC-tarda was by the philosopher John Locke in 1695 (Ash,
1685; Locke, 1695). A doctoral dissertation in 1716 by Carl
Musaeus on ‘‘monstrous nails’’ was apparently the first to
postulate that the constellation of symptoms seen in PC
represented a systemic disease called ‘‘morbus corneus’’
(Musaeus, 1716). The form of PC with widespread pilose-
baceous cysts was first described in the recent literature by
Jackson and Lawler (1951).
Abbreviations: H&E, hematoxylin and eosin; HIM, helix initiation
motif; HTM, helix termination motif; IPCRR, International Pachyo-
nychia Congenita Research Registry; NRIRD, National Registry for
Ichthyosis and Related Disorders; PC, pachyonychia congenita
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
3
Prior to the discovery of the genetic basis of PC, several
clinical classification schemes were proposed (Kumer,
1935; Schonfeld, 1980; Sivasundram et al, 1985; Feinstein
et al, 1988; Dahl et al, 1995). A review of the modern lit-
erature by Feinstein et al (1988) summarized the majority of
PC reports in the worldwide literature and discussed each
of the major classification schemes proposed up to 1985.
Based on these 168 cases of PC reported in the literature,
Feinstein et al (1988) proposed a classification of PC into
four overlapping subtypes which are frequently used in case
reports. The literature was again reviewed in 1995 (Dahl
et al, 1995), and simplified criteria were proposed in which
the diagnosis of PC could be made when the characteristic
nail changes (major criteria) occurred in association with at
least one minor criterion (autosomal dominant inheritance,
palmoplantar keratoderma, leukokeratosis oris, follicular
keratosis, bullae on palms or soles, or laryngeal leukokera-
tosis). Unfortunately, classification of PC by purely clinical
criteria was hindered by significant variability of the pheno-
type, even within affected members of the same family, a
common feature of most or all keratin disorders (Irvine and
McLean, 1999).
Clinical genetics of PC. A major advance in the capacity
to classify PC came in 1995 when the genes encoding
keratins K16 and K17 were identified as harboring the first
genetic mutations underlying PC (McLean et al, 1995), fol-
lowing genetic linkage data showing a probable keratin de-
fect (Munro et al, 1994). These findings were followed by
identification of mutations in keratins K6a and K6b (the po-
lymerization partners of K16 and K17) in additional PC fam-
ilies (Bowden et al, 1995; Smith et al, 1998). To date, over 82
mutations in these four keratins have been identified in in-
dependently ascertained families (Fig 1 and Smith et al, this
issue). Nearly all the reported mutations occur at either the
start or the end of the central keratin rod domain. These
regions are known as the helix boundary motifs of the ker-
atin polypeptide, or, individually, the helix initiation motif (in
the 1A domain) and the helix termination motif (in the 2B
domain). As discussed elsewhere in this issue (Smith et al,
McLean et al), these regions are critically important for end-
to-end association of protein subunits in the assembly of
keratin filaments and, furthermore, represent mutation hot-
spots in all keratin genes so far associated with human
disease phenotypes.
In the genetic studies described above, the phenotypic
classification of PC families into two major subtypes
emerged, termed as PC-1 (or the Jadassohn–Lewandow-
ski type) and PC-2 (or the Jackson–Lawler type) based on
early clinical descriptions (Jadassohn and Lewandowski,
1906; Jackson and Lawler, 1951). The most prominent clin-
ical feature of both PC subtypes is hypertrophic nail dys-
trophy. Specifically, the nail changes in PC consist of three
abnormal findings: hyperkeratosis of the nail bed; thicken-
ing of the nail plate; and distortion or curvature of the nail
plate. Importantly, both PC types also show variable de-
grees of a focal palmoplantar keratoderma with accentua-
tion in weight-bearing or traumatized areas. Both PC-1 and
PC-2 patients sometimes develop follicular keratoses of the
elbows, knees, and hips. The clinical discrimination be-
tween PC-1 and PC-2 usually depends on more prominent
oral leukokeratosis in PC-1, or, conversely, in findings of
steatocystomas/pilosebaceous cysts, vellus hair cysts, hair
abnormalities (alopecia, pili torti (twisted hair)), and natal
teeth in PC-2. The occurrence of natal teeth appears to be
diagnostic of PC-2, but, unfortunately, this feature is not
fully penetrant, i.e., not all PC-2 patients present with natal
teeth. The PC-1 clinical phenotype is associated with mu-
tations in K6a and K16 whereas the PC-2 phenotype is
associated with mutations in K6b and K17. The major
phenotypic differences between the two types are clearly
correlated with known differences in the expression ranges
of these two pairs of keratins (Lane, 1993). A delayed onset,
or tarda subtype of both PC-1 and PC-2 has also been
described and keratin mutations associated with PC-tarda
have been found outside the helix boundary motif regions of
the K16 and K17 proteins (Connors et al, 2001; Xiao et al,
2004). It is tempting to speculate that the tarda phenotype
occurs because these mutations are not so disruptive to
keratin assembly (see McLean et al, this issue), but addi-
tional cases will be necessary to confirm this hypothesis.
Despite the incomplete information available regarding the
mechanistic details, practitioners can now confirm clinical
suspicion of PC by mutation testing.
As genetic testing of PC patients is becoming more
common, the complexity of the relationship between the
keratin mutation status and the clinical phenotype also be-
comes more obvious (Munro, 2001). Mutations within the
same functional domain of the keratins produce variable
clinical manifestations, and even patients with the same
mutation sometimes display different levels of severity and
different clinical spectra. For example, the same mutation in
K17 gives rise to the full PC-2 phenotype in some families
and to steatocystoma multiplex without nail changes in
others (Smith et al, 1997; Covello et al, 1998). Similarly,
mutations in the helix initiation motif of K16 can produce a
full-blown PC-1 presentation (Smith et al, 1999a, b; 2000) or
just focal non-epidermolytic palmoplantar keratoderma in
other cases (Shamsher et al, 1995). The variability of phe-
notype and incomplete penetrance seen in PC strongly
suggests that genetic and/or environmental modifier effects
are modulating the genotype–phenotype relationship. Com-
prehensive investigation of these genotype–phenotype–en-
vironment interactions in PC may ultimately provide
clinically relevant clues to the pathogenesis and optimal
treatment of the disease. Thus, the goals of this paper are to
provide the medical community with a comprehensive re-
view of the clinical and pathological spectrum seen in PC,
report new prospective data on a cohort of 57 PC partic-
ipants, correlate the clinical findings of PC patients with
their genetic mutation status, and provide clinicians with a
user-friendly summary of genetic test results seen in PC.
Results
Literature review and analysis of PC cases Three sourc-
es of cases were evaluated: cases in the literature, cases
from the International Pachyonychia Congenita Research
Registry (IPCRR), and cases from the National Registry for
Ichthyosis and Related Disorders (NRIRD). A comprehen-
sive literature review revealed a total of 198 articles con-
taining 457 independent cases of PC from 214 different
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pedigrees. A complete, searchable bibliography containing
these papers was developed and can be found at http://
www.pachyonychia.org. All cases from these reports were
utilized for the analysis of clinical phenotype. A total of 55 of
these cases have a reported keratin mutation. For a com-
plete listing showing the references used and correspond-
ing data extracted, please see supplemental online
information accompanying this paper (website to be in-
cluded by JID). In addition to the cases from the literature,
57 participants from 41 families were prospectively enrolled
in IPCRR and results of keratin mutation tests were com-
pleted for 33 participants. The 57 IPCRR participants reside
in 10 different countries around the world. A total of 11
participants with PC were identified within the NRIRD and
the mutational status of these participants was unknown.
General clinical characteristics Among PC cases identi-
fied from the literature, IPCRR, or NRIRD, all but three cases
in two unrelated families (Chong-Hai and Rajagopalan,
1977; Haber and Rose, 1986) are consistent with an autos-
omal dominant pattern of inheritance. One of these two re-
ports bases the claim of recessive inheritance upon parental
consanguinity plus the fact that no other family members
exhibited the disease (Chong-Hai and Rajagopalan, 1977);
however, it is more likely that this case represented a spon-
taneous dominant mutation rather than recessive inherit-
ance. In the other possible recessive family, there were two
affected offspring born to consanguineous parents (Haber
and Rose, 1986); however, this could also be explained by
one parent carrying a dominant mutation as a gonadal mo-
saic. In fact, the rate of spontaneous mutation appears to
be relatively high, with 85 of 294 cases (29%) from the lit-
erature reporting a negative family history. Similarly in the
IPCRR, 26 of the 57 participants enrolled (46%) have a
negative family history. Age of onset was typically reported
in the literature as ‘‘by the first year of life,’’ ‘‘during
Figure 1
Keratin mutations in pachyonychia congenita (PC). A schematic representation of the protein domain organization of each of the four keratins
associated with PC is shown (K6a, K6b, K16, and K17). A total of 82 mutations have been published to date including those reported in this issue
(Smith et al). The approximate location of mutations is indicated by numbered boxes. The numbers within the boxes indicate the number of families
reported with mutations in this region, i.e., the number of independent occurrences of mutations. Note that the vast majority of mutations are found
in or near the helix initiation motif in the 1A domain or the helix termination motif at the end of the 2B domain. The numbers below the schematic
represent the amino acid residue number with the protein. The domains shown include the ISIS box (green), and homology subdomains H1 and H2
(blue), and the coiled coil domains 1A, 1B, 2A, and 2B (red), separated by non-helical linkers L1, L12, and L2 (black). Stutter sequences (S) are
underlined.
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childhood,’’ or ‘‘in adulthood.’’ In the literature, 216 of 260
(83%) cases developed within the first year of life, 36 of 260
(14%) developed during childhood, and eight of 260 (3%)
developed during adulthood. In the IPCRR, the ages when
plantar keratoderma appeared were defined as 0–1, >1–19,
and X20 y. Data from the IPCRR were 11 of 57 (19%) be-
fore 1 y of age, 44 of 57 (77%) after the first year but before
age 20, and one of 57 (2%) after age 20. The male:female
ratio from the literature was 1:1 (192 male:191 female),
demonstrating no significant gender bias in development of
the disease; however, of note, two families within IPCRR
have reported gender-based differences in severity of the
disease within the family. Unfortunately, these data are too
limited to draw definitive conclusions. Reports of worsening
of the painful plantar keratoderma with weight gain and
pregnancy, or improvement with weight loss or bed rest,
were common in IPCRR participants. Systematic tracking of
these parameters is now underway.
Frequency of occurrence of clinical features in PC The
most common clinical features of PC and the frequency of
occurrence of these manifestations as reported in the liter-
ature, the IPCRR, and the NRIRD are summarized in Table I.
Of note, in the cases reported in the literature, not every
report commented on each clinical finding. If no mention of
the feature was made, that report was not included in the
overall assessment of frequency. This is likely to lead to an
overestimation of the frequency. The frequency of clinical
findings from the literature was, however, very similar in
most instances to that of the registry data, which were
prospectively collected. The most common of all the find-
ings is onychodystrophy (90%–98%) (Fig 2), followed by
plantar pain (91%–96%), and plantar keratoderma (91%–
96%) (Fig 3). Notable discrepancies between the IPCRR
and literature-based data are in the rate of cyst formation
(35% in IPCRR vs 72% in the literature), laryngeal involve-
ment or hoarseness (16% in IPCRR vs 70% in the literature),
hair involvement (26% in IPCRR vs 53% in the literature),
and natal or prenatal teeth (2% in IPCRR vs 50% in the
literature). It should be noted that the IPCRR data are
strongly skewed toward PC-1 (K6a/K16) cases (Table II).
Specifically, of 55 case studies with known genotypes in the
literature, 26 had K6a/K16 mutations compared with 29 with
K6b/K17 defects, i.e., a PC-1:PC-2 ratio of 1:1.1. In con-
trast, of 33 genotyped case studies collected by the IPCRR,
30 had K6a/K16 mutations compared with three with K6b/
K17 mutations, giving a PC-1:PC-2 ratio of 10:1. It is not
clear why this apparent skewing has occurred, but never-
theless the discrepancies between the IPCRR and litera-
ture-based data, notably the percentage of cyst formation,
may be because of this PC-1/PC-2 bias.
Onychodystrophy Onychodystrophy is the most consist-
ent physical finding observed in PC patients (Table I); how-
ever, the character of the nail changes and the severity of
the dystrophy are variable from patient to patient (Fig 2).
Clinically, all 20 nails are usually (but not always) hard and
thickened and sometimes discolored. The nail findings are
one of the earliest manifestations of the disease and are
frequently affected at or soon after birth. There is a prom-
inent thickening of the nail bed, often with progressive distal
elevation. The surface of the nail can be rough or smooth
and some nails develop a ‘‘pincer’’ or ‘‘omega’’ pattern
whereas other nails taper off prematurely before reaching
the distal fingertip. The fingernails of these patients develop
an apparent recession of the nail plate that leaves the distal
fingertip with a slightly bulging appearance. Constant
grooming of the nails is required to prevent overgrowth
and excessive trauma. The nail dystrophy often results in
difficulty with fine motor skills such as opening drink cans or
bottles. Nail loss and re-growth is frequently associated
with infection and/or trauma.
Palmoplantar keratoderma The palmoplantar keratoder-
ma seen in PC is usually more prominent on the plantar than
the palmar surface (Figs 3 and 4). It is a hard, non-ery-
Table I. Percent of patients with phenotypic symptoms
Phenotype Case studies (N¼481) IPCRR (N¼ 57) NRIRD (N¼11)
Toenails 426 of 435 (98%)a 55 of 57 (98%) Nine of Ten (90%)
Fingernails 424 of 434 (97%) 56 of 57 (98%) Ten of 11 (91%)
Plantar pain 71 of 74 (96%) 54 of 57 (95%) Ten of 11 (91%)
Plantar keratoderma 288 of 312 (92%) 55 of 57 (96%) Ten of 11 (91%)
Oral leukokeratosis 216 of 309 (95%) 43 of 57 (75%) NR
Palmar keratoderma 171 of 215 (80%) 35 of 57 (60%) Seven of 11 (63%)
Follicular keratoses 149 of 189 (79%) 37 of 57 (65%) NR
Cysts (any type) 72 of 100 (72%) 20 of 57 (35%) NR
Larynx (hoarseness) 31 of 44 (70%) Nine of 57 (16%) NR
Hyperhidrosis 111 of 169 (66%) 42 of 53 (79%) 4 of 11 (36%)
Hair abnormalities 64 of 120 (53%) 15 of 57 (26%) 0 of 11 (0%)
Natal/prenatal teeth 54 of 108 (50%) One of 53 (2%) 0 of 11 (0%)
IPCRR, International Pachyonychia Congenita Research Registry; NRIRD, The National Registry for Ichthyosis and Related Disorders; NR not
reported.
aPercentage of reported.
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thematous, focal keratoderma that is accentuated in pres-
sure points of the feet or in areas of chronic use on the
hands (e.g., on the thenar eminences where crutches are
held, or in finger creases). Specialized footwear or insoles
that modify the pressure distribution on the feet can also
alter the pattern of the plantar keratoderma over time. There
is no extension of the keratoderma onto the dorsal aspects
of the hands or feet, unless there has been friction or trauma
in that area. Development of the plantar keratoderma is later
than the nail and oral findings, typically developing at the
time a child begins ambulating and bearing weight. Blister-
ing often precedes the hyperkeratosis, and blisters can of-
ten be seen at the periphery of the hyperkeratosis or
underlying the callosities. Although some degree of kerato-
derma is seen in most PC patients, the severity is highly
variable (Fig 3). The plantar keratoderma is usually exqui-
sitely painful and the level of discomfort experienced is of-
ten out of proportion to the degree of hyperkeratosis
present. Severe cases frequently develop fissuring with
secondary infection and routine paring of the hyperkeratotic
areas is required to control pain.
In our histology specimens, areas of plantar hyperkera-
tosis from patients carrying K6a N171K and L469P muta-
tions show prominent ortho- and parakeratosis surmounting
an acanthotic epidermis (Fig 5). This pattern is compatible
with rapid keratinocyte proliferation and differentiation.
There is no cytologic atypia associated with plantar lesions,
although transformation to squamous cell carcinoma has
been reported in a chronic plantar lesion (Su et al, 1990). In
addition to immunostaining of K14 (expected), K6, K16, K17
are seen in the basal cell layer. K6, K16, K17, and K14
staining persists and K10 staining appears in the suprabasal
epidermis (Su et al, 1990; Wollina et al, 1991).
Follicular keratoses Follicular, keratotic spikes of variable
severity occur primarily in areas of friction such as the
waistband, elbows, and knees (Fig 4). The thickening and
follicular keratoses are more accentuated in individuals who
frequently crawl on their knees to avoid plantar pain. The
primary lesions are reminiscent of severe keratosis pilaris.
Development of the follicular keratoses is usually in child-
hood and they often improve or resolve as the patient ages.
Histologically, the follicular keratoses in our specimens
demonstrate a parakeratotic horn surmounting a broadly
papillomatous and acanthotic epidermis with a pronounced
granular layer (Figs 6 and 7). A few pyknotic keratinocytes
are seen within the upper layers of the epidermis and are
reminiscent of those seen in coronoid lamellae of poro-
keratosis (100  ). The horn can also be orthokeratotic
(Perrot et al, 1973). A normal pattern of expression of ep-
idermal keratins is seen, with suprabasal expression of K6,
K16, and K10, with full-thickness staining with K14 (Fig 7).
Figure 2
Features of onychodystrophy in pachyonychia congenita (PC) patients. The clinical appearance of nail dystrophy is shown in PC patients with
defined keratin mutations (shown below each panel). Variation in nail thickening and subungal hyperkeratosis is apparent in all images and illustrated
especially well by comparison of K6a L170F and K6a L469P. Distal hyperpigmentation of the nails is seen in patients with the K6a L469P, K6a I462N,
and K16 N125D mutations. Premature tapering of the nails (nail recession) is seen in individuals carrying mutations K6a N171K, K6a N171del, and
K6b E472K. Sparing of the proximal nail is seen in some patients (K6a L469P, K6b E472K, K6a L170K, K6a I462N). ‘‘Pincer’’ nails or ‘‘Omega’’ sign is
apparent in some cases when examined end-on (K6a I462N). One example of onycholysis is shown (mutation K6a N171K).
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Cysts PC patients are susceptible to developing cysts (Fig
8), including epidermal inclusion cysts, and pilosebaceous
cysts such as steatocystomas and vellus hair cysts (Fein-
stein et al, 1988; Su et al, 1990; Moon et al, 1994). The
epidermal inclusion cysts are extremely variable in size and
severity. Some patients have only an occasional lesion that
is less than 1 cm, whereas others have numerous lesions
greater than 5 cm in diameter. These cysts have a punctum,
contain a cheesy keratinous material, and frequently be-
come painful, inflamed, and infected. The pilosebaceous
type of cysts, including steatocystoma and vellus hair cysts,
are typically round to oval, flesh-colored to yellow dermal
papules without a visible punctum located on the face and
upper trunk and arms. Despite previous reports to the con-
trary, PC-1 patients develop typical epidermal inclusion
cysts in an intertriginous distribution which can occasionally
be severe enough to resemble hidradenitis suppurativa (Fig
8). PC-1 patients do not appear to develop steatocystomas
or vellus hair cysts. Conversely, PC-2 patients develop all
types of cysts, including epidermal inclusion cysts, pilose-
baceous cysts, steatocystomas, and vellus hair cysts. Al-
though steatocyst and vellus hair cyst formation appears to
be a reliable discriminator between PC-1 and PC-2 sub-
types, the delay in onset until the time of puberty makes it
less helpful. In Fig 7, a small epidermal inclusion cyst is
shown, which is lined by stratified squamous epithelium
with primitive hair follicle differentiation (100  ) derived
from a carrier of the N171K mutation in K6a. Suprabasal
keratinocytes are immunoreactive with K6, K16, and K10,
whereas K14 stains the full thickness of the epithelium and
hair follicle (Fig 7).
Oral manifestations Oral leukokeratosis of the tongue and
buccal surfaces of the mouth are frequently seen in PC (Fig
9). The gingival surfaces are rarely involved. These oral
findings often present soon after birth and may be the ear-
liest sign of PC. The leukokeratosis can be worsened by
and interfere with breastfeeding in infancy. The tongue de-
velops a white-to-yellow thickening that can mimic oral
candidiasis, white sponge nevus, or hairy tongue. The clin-
ical appearance of the buccal leukokeratosis resembles
pre-malignant leukoplakia, but is often accentuated along
the bite line. Another common, intermittent oral manifesta-
tion is angular cheilitis. The cheilitis frequently demonstrates
secondary bacterial and yeast infection. Histologically, no
cytological atypia is observed. The mucosal lesions show
acanthosis and marked parakeratosis in the absence of a
granular layer (Fig 7). The pathology is similar to that seen
Figure 3
Plantar keratoderma in pachyonychia congenita. The pressure point distribution of plantar keratoderma is highly variable (all images). Note the
variation of keratoderma among individuals with same mutation (K16 L132P, bottom right). There is evidence of blistering preceding formation of
hyperkeratosis in some patients (K6a N171del, top: second from right) and fissuring (K6a N171del, top right).
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with white sponge nevus caused by keratin K4 or K13 mu-
tations (Richard et al, 1995; Rugg et al, 1995), but there is no
dyskeratosis in PC.
Laryngeal lesions Laryngeal involvement usually presents
as hoarseness and occasionally as a life-threatening respi-
ratory stridor requiring emergent tracheotomy. Assessment
of this finding is subjective because of the invasive nature of
the requisite diagnostic laryngoscopy. In cases in which la-
ryngoscopy and biopsy have been performed, however, the
larynx demonstrates a white-to-pink thickening or an ex-
ophytic mass formation (Cohn et al, 1976; Benjamin et al,
1987; Wudy et al, 1995). Histologically, there is a hyper-
plastic squamous epithelium with focal intracellular vac-
uolization that spares the basal layer. Cellular atypia is not
present. Several IPCRR participants report that overuse or
speaking in a loud voice seems to precipitate hoarseness,
but because laryngoscopy has not been performed in these
cases, the nature of the hoarseness is not known. Most
trauma-induced hoarseness, however, resolves over 1–2 d.
One confirmed death because of respiratory compromise
from laryngeal involvement has been reported to the IPCRR,
and practitioners need to be aware of this severe compli-
cation (see Smith et al, this issue).
Dentition PC-2 patients sometimes present with teeth at
birth (prenatal or natal) or within the first 30 d of life (neo-
natal). These teeth are typically located in the frontal posi-
tion, are soft and friable, are prone to caries, and are usually
lost within the first few months of life (Clementi et al, 1986;
Feinstein et al, 1988; Munro et al, 1994; Munro, 2001). Natal
teeth may cause lacerations of the infant’s tongue or moth-
er’s breast during breastfeeding and can be an aspiration
risk. In some cases, second primary teeth will develop in
addition to the natal teeth but are ultimately replaced by
normal permanent teeth during childhood. In addition to
natal teeth, some IPCRR participants have reported early
multiple tooth development at 4–5 mo of age as well as one
case of early tooth loss without immediate permanent tooth
replacement. Histologically, the dental papillae show mu-
cosal hyperplasia and irregular rete ridge proliferation. Cy-
toplasmic vacuolization and edema are seen in the upper
and spinous layers of the mucosa. Irregular osteodentine-
like structures with cell inclusions and interglobular dentine
are seen (Anneroth et al, 1975). The finding of natal teeth is
not consistently present, even within the same PC-2 family.
Thus, the existence of natal or prenatal teeth is highly sug-
gestive of a PC-2 phenotype and a probable K6b/K17 mu-
tation, but absence of this finding does not suggest a PC-1
phenotype.
Hair manifestations Hair manifestations are most com-
monly seen in PC-2 patients, although PC-1 patients in the
IPCRR have reported hair abnormalities (Irvine and McLean,
1999; Munro, 2001). Hair is thickened or coarse and some-
times brittle or curly. Pili torti (twisted hair) has been report-
ed in association with PC-2 (Irvine and McLean, 1999;
Munro, 2001). K17 has been shown to be expressed not
only in the sebaceous gland and infundibulum of the hair
follicle, but also in the hair shaft itself (McGowan and Cou-
lombe, 2000). Mice in which the K17 gene has been ablated
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develop age- and strain-dependent alopecia, again con-
sistent with a hair phenotype associated with PC-2 (McGo-
wan et al, 2002), although the null mutations in these mice
are obviously different from those commonly seen in PC-2.
Hair findings become apparent when the hair grows in dur-
ing early childhood. The hair findings are not consistently
present, even within PC-2 patients and are variably pene-
trant within a given family. If hair abnormalities are seen in
conjunction with pilosebaceous cysts or in a patient who
had natal or prenatal teeth, it is virtually diagnostic of a PC-2
phenotype. Hair findings associated only with onychodys-
trophy and/or palmoplantar keratoderma, however, are not
good predictors of PC-1 (K6a/K16) versus PC-2 (K6b/K17)
phenotypes.
Other clinical features in PC Additional features of PC
have been reported, but are extremely rare and not clearly
related to PC. These features include deafness, mental
disability, cataract formation, skeletal changes, delayed
development of genitalia, and corneal dyskeratosis
(Moldenhauer and Ernst, 1968). In one reported family, au-
tosomal dominant cataract formation was shown to be an
unrelated coincidental finding in some members affected by
PC-1 and carrying a K16 mutation (Smith et al, 1999a). The
IPCRR has also identified additional findings that may be
associated with PC but for which there is still limited data.
These features include excessive production of a waxy
material in the ears (29 of 57), corneal abnormalities (two of
57), and abnormal cytology on pap smears (two of 57).
Genotype–phenotype relationships in PC An evaluation
was also performed of all the IPCRR registry participants
and of case reports in whom a mutation has been reported
(Table II). Patients with identical mutational status de-
monstrated a variable phenotype (Table II; Figs 2–5). As
described above, the phenotypic features of PC can be
subdivided into a PC-1 (K6a or K16) and PC-2 (K6b or K17)
subtype based on a few specific clinical features. The
phenotypic features reported in the literature and through
IPCRR were subdivided by the type of keratin mutation
carried by the patient (Table II). Most features demonstrated
no association with a specific keratin mutation (K6a, K6b,
K16, or K17). The data from the literature and from the
IPCRR do support increased hair involvement, natal tooth
development, and cyst formation in PC-2 relative to PC-1,
but it again should be noted that most IPCRR-identified
cases carried K6a/K16 mutations (30 of 33). The phenotypic
features were also divided based on which functional do-
main of the keratin contained the mutation: the helix initi-
ation motif (HIM), or helix termination motif (HTM), as shown
in Table III. Although the data are limited, it is possible that
mutations in the HTM may be more pathogenic in the larynx
(eight of 11 cases in the HTM vs four of 22 cases in the HIM)
and that mutations in the HIM may be more pathogenic in
the hair (seven of 22 cases in the HIM vs two of 11 cases in
the HTM). Furthermore, the non-HIM/HTM mutations may
be associated with a late-onset (tarda) presentation (Con-
nors et al, 2001; Xiao et al, 2004), as discussed elsewhere
in this issue (Smith et al, McLean et al). Overall, numbers
are still too small to make firm genotype–phenotype
conclusions.
Quality-of-life issues in PC Few quality-of-life questions
were included in the IPCRR questionnaire; however, the
participants were asked about the time required for groom-
ing and concerns about the cosmetic appearance of their
skin and nails. Of 57 participants, 38 reported that time for
skin and nail care negatively impacted their quality of life
and 45 reported cosmetic concerns that negatively impact-
ed their quality of life. In addition, 29 of 57 participants re-
Figure 4
Keratotic follicular spikes. Examples of folli-
cular spikes occurring in areas of friction such
as the elbow (K6a N171del), waistband (K6a
N171K), knees (K6a L468P), and palms (K6a
N171K and K16 N125D) are shown.
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ported an inability to ambulate without a walking aid
(crutches, wheelchair, etc.) and 12 of 57 reported that they
are unable to work or attend school because of the severity
of their condition. The plantar pain is reported as the most
disabling feature (54 of 57 cases), something which has
been underrecognized until now. Several IPCRR partici-
pants have elected not to have children because of the fear
of having a child with PC; however, first-trimester prenatal
diagnosis is now possible for individuals with characterized
mutations (Smith et al, 1999b).
Discussion
PC is a rare, but well-characterized genetic disorder of the
nails, skin, hair, and mucosa that exhibits significant
phenotypic variability across genotypic groups and fami-
lies. In order to evaluate which features are most consist-
ently seen in the disorder as well as evaluate the spectrum
of presentation, we have analyzed case reports from the
literature and prospectively collected data from the IPCRR
and NRIRD. We have added 313 additional cases to the 168
Figure 5
Hemotoxylin and eosin (H&E) staining and anti-
keratin immunostaining of plantar biopsy mate-
rial. Plantar biopsy material from two pachyonychia
congenita (PC) patients with defined mutations and
a normal unrelated control were analyzed by H&E
staining and immunohistochemical staining with
keratin antibodies. In normal skin, there was a sim-
ilar suprabasal keratin immunostaining pattern seen
for K6, K16, K10, whereas K17 and K14 showed
diffuse epidermal staining that included the basal
cell layer. In specimens from the patients carrying
the K6a N171K and K6a L469P mutations, there is
a prominent orthokeratosis and parakeratosis
surmounting an acanthotic epidermis. Keratin im-
munostaining showed diffuse epidermal staining,
including the basal cell layer, for K6, K16, K17, and
K14. The K6aN171K sample shows markedly
decreased K10 expression. All scale bars¼100 mm.
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Figure 6
Follicular keratoses from the knee in pachyo-
nychia congenita (PC). Epidermal biopsy material
from the knees of two PC patients with defined
mutations and a normal unrelated control were
analyzed by hematoxylin and eosin (H&E) staining.
Hyperkeratosis and epidermal papillomatosis was
observed in the K6a patient as compared with
the normal control and K16 subject. All scale
bars¼100 mm.
Figure 7
Comparative histology and immunostaining on
biopsies from a K6a N171K mutation carrier.
Dermal cyst: Cysts were seen to be lined by strat-
ified squamous epithelium with primitive hair follicle
differentiation (100  ). The cyst was immunoreac-
tive with K6, K16, and K10, whereas K14 stains the
full thickness of the epithelium and hair follicle.
Follicular hyperkeratosis: A few pyknotic keratin-
ocytes were seen within the upper layers of the
epidermis and are reminiscent of those seen in co-
ronoid lamellae of porokeratosis (100  ). The nor-
mal pattern of expression of epidermal keratins was
seen, with suprabasal expression of K6, K16, and
K10, with full-thickness staining with K14. Oral le-
ukokeratosis: hemotoxylin and eosin (H&E) staining
revealed acanthotic squamous mucosa surmount-
ed by parakeratosis in the absence of keratinocyte
ayptia. Similar suprabasal immunoreactivity with K6
and K16 was seen, although K10 staining is patchy
and is present mostly within the superficial kera-
tinocyte layers. Strong K14 immunoreactivity was
observed over the full-thickness of the squamous
mucosa. All scale bars¼100 mm.
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cases included in the metaanalysis of Feinstein et al in 1988.
In addition, 57 participants enrolled in the IPCRR and 11
participants enrolled in the NRIRD were reported here. The
combination of these data sets permits us to draw more
informed conclusions regarding the clinical and pathological
features of PC and the genotype–phenotype relationships.
Literature-based metaanalyses, however, have potential
sources of bias and misinterpretation. In particular, cross-
study comparisons are difficult to perform because of
reporting inconsistencies. Retrospectively, it is frequently
unclear whether lack of discussion of a particular symptom
is because of absence of the finding, or a failure to report an
unrecognized component of the phenotype. Therefore, we
calculated our percentage of cases having a given clinical
finding from the total number of cases in which the finding
was reported rather than the total number of case reports.
Although better than using the total overall number of cas-
es, this method leads to an overestimation of the incidence
of any given finding because of the tendency of authors to
report positive findings. In addition, reports of unusual
presentations of rare disorders are preferentially published,
also leading to an overestimation of the number of cases
with unusual findings. Thus, it is unlikely that a rare finding
such as corneal dyskeratosis is actually found in 7.8% of
PC cases as reported previously (Feinstein et al, 1988).
Another source of bias in reporting includes findings that
cannot be visually confirmed, such as laryngeal thickening.
Although prominent hoarseness may be an indication of la-
ryngeal involvement, the number of PC cases with laryngeal
involvement is probably underestimated because laryngos-
copy is not a routine part of the examination and assess-
ment of hoarseness is subjective. Additionally, historical
reports of findings such as mental retardation in association
with PC are often difficult to interpret because of lack of
clarity of the degree or type of mental impairment, lack of
comment regarding co-segregation with PC in the family,
and lack of comparison of rate of occurrence relative to the
general population. Thus, although defining PC subtypes
based on summaries of clinical case reports was a neces-
sary exercise in order to begin to investigate and under-
stand the syndrome, this method of classification is also
fraught with many potential sources of confusion. Because
of these multiple sources of bias, we have categorized all
the less commonly associated features as ‘‘other clinical
features’’ rather than attempting to estimate incidence
rates.
A superior alternative to collecting cases from the world-
wide literature is to collect cases prospectively through a
registry in which information can be consistently obtained.
But in disorders as rare as PC, collecting adequate numbers
is difficult. For example, our set of 57 IPCRR participants
represents the largest prospectively enrolled group of PC
patients described to date, but is still small, especially if
subset analysis is attempted. Also, Internet access to
IPCRR contact information is a likely source of bias toward
a more affluent and better-educated population. Therefore,
rather than attempting to draw definitive conclusions about
genetic subsets of our IPCRR population, we present the
raw data for the reader to evaluate (Tables II and III).
Despite the considerable difficulties in evaluating the
clinical and pathological phenotypes of PC, our data col-
lectively support the conclusion that there are two primary
Figure 8
Cysts associated with pachyonychia congenita (PC). Steatocysts
(or pilosebaceous cysts) are commonly found on the face (K17 N92S)
and are widespread across the trunk (K6b E472K) in post-pubescent
PC-2 individuals. Inclusion cysts are usually found on the trunk (K16
N125D) and axilla (K6a N171del) in PC-1 cases.
Figure 9
Oral leukokeratosis in pachyonychia
congenita (PC). Oral leukokeratosis ap-
pears to be more pronounced in K6a
mutation carriers. Note this is similar in
clinical appearance to oral candidiasis.
Angular chelitis can also be observed in
PC patients (K6a L468P shown here).
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clinical categories of PC (PC-1 and PC-2) and that they
correlate well with mutations in K6a/K16 and K6b/K17, re-
spectively. The best discriminating clinical features include
findings of natal teeth, pilosebaceous cysts, or hair abnor-
malities in K6b/K17 mutation carriers, but incomplete pene-
trance and overlap of these findings make clinical
examination a poor discriminator. It is also clear that dra-
matic phenotypic diversity exists, both in terms of the exact
features that are present and in the severity of the finding.
For example, PC without nail findings has been reported
and steatocystoma multiplex with natal teeth has been re-
ported as a ‘‘new syndrome’’ (King and Lee, 1987), but
molecular analysis of similar cases has revealed K17 mu-
tations (Smith et al, 1997; Covello et al, 1998). Thus, at least
some cases of steatocystoma multiplex are allelic variants
of PC-2. Similarly, some families carrying mutations in K16
present with focal non-epidermolytic palmoplantar kerato-
derma with very trivial or no nail changes (Shamsher et al,
1995; Smith et al, 2000), showing that this condition is allelic
with PC-1 (see also Smith et al, this issue). Even within a
single family, considerable clinical variability may be ob-
served, suggesting that environmental or co-inherited
genetic modifiers play an important role in disease
manifestation. This feature of PC may ultimately be of
benefit to patients because once the modifier effects are
identified they may be utilized in a therapeutic role.
Unfortunately, identifying genetic modifiers is difficult or im-
possible in humans using genetic linkage approaches be-
cause of limitations on pedigree size; however, this is more
tractable using mouse genetics.
Based on the questionnaire data from the IPCRR, it ap-
pears that the quality of life of PC patients is significantly
compromised, and further investigation of this finding is
warranted. The most common debilitating feature is not the
most obvious (nails), but rather the plantar pain. In addition,
laryngeal involvement may be more common and more se-
rious than originally believed. As respiratory compromise
may be preceded by a hoarse cry, all parents of infants with
PC should be educated to listen for hoarseness and watch
for signs of respiratory compromise to permit corrective
surgery when necessary. Because of the rarity of PC, sur-
gical pathologists need to be advised of the underlying
condition at the time of biopsy in order to facilitate clinico-
pathologic correlation and correct diagnosis.
Clinicopathologic correlations reveal that the underlying
defect in PC is probably similar to that of other keratin
disorders such as epidermolysis bullosa simplex
or epidermolytic hyperkeratosis, namely skin fragility. His-
tologically, vacuolization of suprabasal keratinocytes is
seen in most affected areas. Blister formation is common
on the plantar surface and blisters are easily induced on the
feet of PC patients by the pencil–eraser friction method
(S. A. Leachman, unpublished observation). The plantar
keratoderma becomes worse when stress forces are in-
creased: by increasing weight bearing, hydrating the stra-
tum corneum, or walking long distances. Buccal mucosal
involvement is accentuated along the bite line. Palmar in-
volvement is distributed in areas of chronic use. Similarly,
follicular keratoses also develop in areas of friction. These
findings point to keratinocyte fragility as a prominent patho-
mechanism in PC. Of further consequence is the fact, in
addition to constitutive expression in the tissues of involve-
ment, that expression of the keratin pairs associated with
PC, K6a/K16, and K6b/K17 is induced by wound healing
and trauma. This creates a cycle in which keratinocyte
fragility leads to increased damage or trauma, which leads
to increased expression of deficient keratins, which leads to
increased fragility, and so on. We hypothesize that the
Table III. Clinical features of PC based on location of keratin mutation
Phenotype
Case studies with known genotype (N¼ 48) IPCRR with known genotype (N¼ 33)
1AHIMa (N¼ 45) All other domains (N¼ 1) 2BHTMb (N¼ 2) 1AHIMb (N¼ 22) 2BHTMb (N¼ 11)
Toenails 43 of 44 (98%)c One of one (100%) Two of two (100%) 21 of 22 (95%) 11 of 11 (100%)
Fingernails 42 of 44 (95%) One of one (100%) Two of two (100%) 22 of 22 (100%) Ten of 11 (91%)
Plantar pain Four of four (100%) NR NR 22 of 22 (100%) 11 of 11 (100%)
Plantar keratoderma 28 of 33 (85%) Zero of one (0%) Two of two (100%) 22 of 22 (100%) 11 of 11 (100%)
Oral leukokeratosis 14 of 31 (45%) NR Two of two (100%) 18 of 22 (82%) Eight of 11 (73%)
Palmar keratoderma 13 of 20 (65%) Zero of one (0%) Two of two (100%) 14 of 22 (64%) Ten of 11 (91%)
Follicular keratoses Ten of 20 (50%) One of one (100%) Zero of two (0%) 13 of 22 (59%) Seven of 11 (64%)
Cysts (any type) 21 of 30 (70%) Zero of one (0%) Zero of two (0%) Seven of 22 (32%) Four of 11 (36%)
Larynx (hoarseness) Zero of one (0%) NR NR Four of 22 (18%) Eight of 11 (72%)
Hyperhidrosis One of one (100%) Zero of one (0%) NR 15 of 21 (71%) Ten of ten (100%)
Hair abnormalities Zero of one (0%) NR NR Seven of 22 (32%) Two of 11 (18%)
Natal/prenatal teeth Six of 26 (23%) Zero of one (0%) Zero of two (0%) Zero of 22 (0%) Zero of 11 (0%)
PC, Pachyonychia Congenita; IPCRR, International Pachyonychia Congenita Research Registry; HIM, helix initiation motif; HTM, helix termination
motif; NR not reported.
aN terrminus
bC terrminus
cPercentage of total reported for location of specific keratin mutation
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plantar keratoderma in PC is an accentuation of ‘‘normal’’
callusing that occurs following trauma. Just as a normal
individual develops blisters and subsequent calluses fol-
lowing a day of hard work, the PC patient develops blisters
and compensatory callus formation. But unlike the normal
individual, the callus is not transient or protective, but rather
further increases fragility by increasing shear forces and by
having elevated levels of the pathogenic, trauma-induced
keratins.
We were unable to identify any histological or im-
munohistochemical features that are pathognomonic for
PC or for a specific keratin mutation. Thus, at the present
time, the most objective definition of PC subtypes comes
from mutation analysis of the keratin genes: mutations in
K6a or K16 result in PC-1 whereas defects in K6b or K17
cause PC-2. The discovery of the molecular basis of PC
gives physicians the capacity to classify the disease based
upon the mutational status rather than relying on variable
and subjective physical examination. Given the number of
genetic tests that have now been performed for PC patients
(Fig 1), it is now relatively straightforward to provide useful
and accurate genetic counseling information to PC patients.
In addition, the comparison of a variety of patients with
similar mutations will ultimately allow physicians to better
appreciate the full spectrum of the disease. Indeed, it is
likely that comparison of patients with the same mutation
may lead to the recognition of other genetic or environ-
mental modifier effects and help elucidate fundamental
mechanisms of pathogenesis.
Conclusions
In summary, mutations in K6a/K16 or K6b/K17 are associ-
ated with clinical phenotypes PC-1 and PC-2, respectively.
Mutation screening of these keratin genes in patients with
the PC phenotype will allow confirmation of the clinical di-
agnosis, classification of the PC subtype based on geno-
type, and provide the option for prenatal genetic diagnosis.
In addition, the phenotypically and genotypically defined
cohort of the IPCRR will be crucial for future clinical trials
when testing therapeutic agents under development in lab-
oratories around the world.
Materials and Methods
Literature searches and analysis of reported PC cases A com-
prehensive literature review was performed which included a Pub-
Med/MEDLINE search for primary references, a collection and
review of all relevant secondary references from these original
sources, and translation of most non-English language articles.
The search string used was: [pachyonychia OR Jadassohn OR
Jackson-Lawler OR keratoderma OR onychogryphosis OR keratin
6a OR K6a OR keratin 6b OR K6b OR keratin 16 OR K16 OR
keratin 17 OR K17 OR steatocystoma OR follicular keratosis OR
leukoplakia OR leukokeratosis]. This search revealed 8868 primary
articles, many unrelated to PC. The titles and abstracts of these
articles were reviewed and 282 papers relevant to PC (or with the
potential of having a case report of PC) were identified and ob-
tained. Each of the primary papers was reviewed and an addi-
tional 246 references were selected for a total bibliography of 582
articles. Of these references, more than 80 non-English language
articles were translated (31 German, 19 French, two Italian, two
Japanese, 13 Russian, nine Spanish, two Dutch, one Latin, and
one Hungarian). A total of 41 references were not available for
review. For analysis of case reports, each reference was reviewed
and each clinical feature of interest was assigned a status of ‘‘af-
fected,’’ ‘‘unaffected,’’ or ‘‘unreported.’’ The percentage of cases
affected was calculated by utilizing the number of affected cases
divided by the total number reported (i.e., affected plus unaffect-
ed). The undocumented cases were not included in the calculation.
IPCRR The IPCRR is a research registry resource approved by an
Institutional Review Board (IRB) that complies with all principles of
the Helsinki Accord (Western IRB #1057496). Participant recruit-
ment is primarily by self-referral to the web-based registry (http://
www.pachyonychia.org/Registry.html), although direct physician
referral occurs as well. Participants in the registry have the option
to complete an epidemiologic, genetic, and medical history ques-
tionnaire, provide clinical photographs, receive mutation testing
(K6a, K6b, K16, K17), and donate blood or tissue samples for re-
search purposes. Each participant that completes a questionnaire
and provides a series of standard photographs (or receives a
physical examination by S.A.L.) undergoes a medical consultation
(S.A.L.) in order to establish the diagnosis and determine the ap-
propriateness of genetic testing. If clinical suspicion for PC is con-
firmed, the participant receives genetic counseling and is referred
for mutation testing. Mutation status is determined by sequence
analysis in a research laboratory (W.H.I.M. and F.J.D.S.) and is
verified in the clinical laboratory of GeneDx (Gaithersburg, Mary-
land). As with the case reports, the percentage of cases affected
was calculated by utilizing the number of affected cases divided by
the total number reported; the undocumented cases were not in-
cluded in the calculation.
NRIRD The NRIRD has for more than 10 y been an IRB-approved
research registry (FWA#: 00006878) that has been collecting data
according to the Declaration of Helsinki principles on participants
with ichthyotic skin diseases.
Tissue collection Five IPCRR participants, two with mutation
N171K in K6a, one with mutation L469P in K6a, one with mutation
N125D in K16, and a normal control participant, provided tissue
specimens for the study. Biopsy sites included the buccal mucosa,
knee, foot, normal buttock, axillary and inguinal cysts, and follicular
keratosis of the buttock. Each tissue was split into two sections
and either formalin fixed and paraffin embedded or frozen in
optimal cutting temperature Tissue-Tek embedding medium
(Sakura Finetek, Torrance, CA) embedding medium for frozen sec-
tioning. Each sample was stained or immunostained as described
below.
Histology Routine hematoxylin and eosin (H&E) staining was
performed to evaluate morphologic features of each specimen.
Immunoperoxidase staining of frozen and paraffin-embedded sec-
tions utilized the Dako Envision system (catalog number K4007,
DakoCytomation, Denmark). This is a sensitive system based on
horseradish peroxidase-conjugated secondary antibodies to re-
duce non-specific staining. Paraffin and frozen 7 mm sections were
cut and placed on electrostatically charged slides for improved
binding (Superfrost slides, catalog number 406/0179/00, VWR In-
ternational, Bristol, CT). Paraffin sections were deparaffinized and
endogenous peroxidase activity was blocked by incubation in
0.3% hydrogen peroxide in methanol. Sections were rehydrated
and antigen retrieval was accomplished by autoclaving at 1201C
for 20 min in antigen unmasking solution (H-3300, Vector Labs,
North Holland) using the 2100 Retriever autoclave (Pickcell Lab-
oratories, Peterborough, UK, the Netherlands) and allowing sec-
tions to cool for at least 2 h.
Frozen and antigen-retrieved paraffin-embedded sections were
rinsed in phosphate-buffered saline (PBS) and incubated in primary
antibody solution in a humidified chamber. One hour incubations of
the following primary antibodies were performed: (1) 1:10 dilution
anti-cytokeratin 10 (LHP1, Novocastra Laboratories Ltd, Newcastle-
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upon-Tyne, UK; (2) 1:10 dilution anti-cytokeratin 14 (LL002, from
E.B.L. Laboratory, Dundee, UK); (3) 1:20 dilution anti-cytokeratin 6
(Ks6.KA12, Progen Biotechnik GmbH, Heidelberg, Germany); (4)
1:10 dilution anti-cytokeratin 16 (LL025, from E.B.L. Laboratory); (5)
1:20 dilution anti-cytokeratin 17 (E3, from Vector Laboratories,
Burlingame, California). After primary antibody incubation, the
sections were washed in PBS. Anti-mouse peroxidase-labeled
polymer (Dakocytomation Envision System, Cambridgeshire, UK)
was applied undiluted for 30 min, washed in PBS, and developed
with the DAB/substrate-chromogen system from Dakocytomation.
Slides were counterstained with hematoxylin.
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